100 Years of Suramin

Antimicrob Agents Chemother. 2020 Feb 21;64(3):e01168-19. doi: 10.1128/AAC.01168-19. Print 2020 Feb 21.

Abstract

Suramin is 100 years old and is still being used to treat the first stage of acute human sleeping sickness, caused by Trypanosoma bruceirhodesiense Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism. Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place? Here, we provide an overview of the many different candidate targets of suramin and discuss its modes of action and routes of cellular uptake. We reason that, once the polypharmacology of suramin is understood at the molecular level, new, more specific, and less toxic molecules can be identified for the numerous potential applications of suramin.

Keywords: Trypanosoma brucei; human African trypanosomiasis; polypharmacology; sleeping sickness; suramin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Suramin / therapeutic use*
  • Trypanocidal Agents / therapeutic use*
  • Trypanosoma brucei rhodesiense / drug effects
  • Trypanosoma brucei rhodesiense / pathogenicity
  • Trypanosomiasis, African / drug therapy*
  • Trypanosomiasis, African / parasitology

Substances

  • Trypanocidal Agents
  • Suramin